Newsfeeds - Spark Newswire

2 minute read

BioVie Announces Completion Of Patient Enrollment In Phase 3 Trial Assessing NE3107 In Alzheimer’s Disease

Today, 2:03 PM

BioVie Inc. (NASDAQ:BIVI) ("BioVie" or the "Company"), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced

BIVI

2 minute read

Analyzing BioVie’s Short Interest

By Benzinga Insights

Today, 2:03 PM

BioVie's (NASDAQ:BIVI) short percent of float has risen 27.02% since its last report. The company recently reported that it has 612 thousand shares sold short, which is 6.77% of all regular shares that are available for trading.

BIVI

4 minute read

Why Horizon Global Shares Are Trading Higher By Over 340%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

Today, 2:03 PM

Gainers Horizon Global Corporation (NYSE: HZN) shares surged 341% to $1.7161 after the company announced it will be acquired by First Brands Group.

ACMR

2 minute read

How Is The Market Feeling About BioVie?

By Benzinga Insights

Today, 2:03 PM

BioVie's (NASDAQ:BIVI) short percent of float has risen 67.61% since its last report. The company recently reported that it has 379 thousand shares sold short, which is 5.33% of all regular shares that are available for trading.

BIVI

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

Today, 2:03 PM

Gainers Athenex (NASDAQ:ATNX) stock moved upwards by 41.4% to $0.19 during Tuesday’s regular session. Trading volume for this…

ATNX

2 minute read

EXCLUSIVE: Benzinga Moneymaker Series: Top 5 Stocks For Investors To Watch

By Chris Katje

Today, 2:03 PM

Investors are on the hunt for undervalued, underfollowed and emerging stocks to spot opportunities. The rise of social media and retail traders gave way to countless methods to uncover new information. For some, this is overwhelming.

BAC

4 minute read

Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

Today, 2:03 PM

Gainers Ambrx Biopharma Inc. (NYSE: AMAM) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate.

ACER

4 minute read

Why Express Shares Are Trading Higher By 39%? Here Are 50 Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

Today, 2:03 PM

Gainers My Size, Inc. (NASDAQ: MYSZ) shares jumped 88% to $0.2839. My Size announced a 1-for-25 reverse stock split.

AMAM

4 minute read

Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 2:03 PM

Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC met the primary endpoint.

ALVO

3 minute read

US Stocks Mixed; Dow Rises 50 points

By Lisa Levin

Today, 2:03 PM

U.S. stocks traded mixed this morning, with the Dow Jones gaining more than 50 points on Wednesday.

BIVI